-
IntroducedApr 06, 2023
-
Passed House
-
Passed Senate
-
Signed into Law
AN ACT INCREASING THE RATE OF THE CREDIT REFUND VALUE FOR CERTAIN EXPENDITURES BY BIOTECHNOLOGY COMPANIES. To increase the rate of the credit refund value for research and experimental expenditures or research and development expenses of biotechnology companies.
Last Action See all actions
House • May 04, 2023: File Number 718 (LCO)
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on HB 6932
Tweets
Whip Lists
Sponsors
- Finance
Votes
YES: 51
- Fonfara J
- Meskers S
- Horn M
- Morrin Bello A
- Martin H
- Mushinsky M
- Cheeseman H
- Napoli R
- Miller P
- Needleman N
- Moore M
- Paolillo A
- Farrar K
- Pavalock-D'Amato C
- Barry J
- Perillo J
- Bronko S
- Piscopo J
- Brown M
- Polletta J
- Bumgardner A
- Rahman M
- Butler L
- Sanchez J
- Cabrera J
- Sanchez R
- Carney D
- Santiago H
- Cohen C
- Stafstrom S
- Concepcion J
- Veach D
- Dancho L
- Wilson D
- Doucette J
- Wood K
- Elliott J
- Yaccarino D
- Fazio R
- Zullo J
- Gee F
- Zupkus L
- Hall J
- Harding S
- Hwang T
- Kavros DeGraw E
- Klarides-Ditria N
- Lemar R
- Lopes R
- Luxenberg G
- Maroney J
NO: 0
OTHER: 0
Actions
- May 04, 2023 | House
- Reported Out of Legislative Commissioners' Office (LCO)
- Favorable Report, Tabled for the Calendar, House
- House Calendar Number 476
- File Number 718 (LCO)
- Apr 28, 2023 | House
- Referred to Office of Legislative Research and Office of Fiscal Analysis 05/03/23 5:00 PM (LCO)
- Apr 20, 2023 | House
- Filed with Legislative Commissioners' Office (LCO)
- Apr 19, 2023 | House
- Joint Favorable (FIN)
- Apr 10, 2023 | House
- Public Hearing 04/14
- Apr 06, 2023 | House
- Referred to Joint Committee on Finance, Revenue and Bonding